1. Home
  2. BATRK vs HAE Comparison

BATRK vs HAE Comparison

Compare BATRK & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atlanta Braves Holdings Inc. Series C

BATRK

Atlanta Braves Holdings Inc. Series C

HOLD

Current Price

$53.05

Market Cap

3.4B

Sector

Industrials

ML Signal

HOLD

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$108.18

Market Cap

3.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BATRK
HAE
Founded
1991
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.8B
IPO Year
2023
1996

Fundamental Metrics

Financial Performance
Metric
BATRK
HAE
Price
$53.05
$108.18
Analyst Decision
Buy
Buy
Analyst Count
2
9
Target Price
$60.00
$84.13
AVG Volume (30 Days)
597.1K
875.0K
Earning Date
05-11-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
26.00
N/A
EPS
N/A
0.72
Revenue
$732,492,000.00
$910,373,000.00
Revenue This Year
$12.40
N/A
Revenue Next Year
$8.54
$5.23
P/E Ratio
N/A
$150.56
Revenue Growth
10.52
N/A
52 Week Low
$37.76
$47.32
52 Week High
$54.46
$109.57

Technical Indicators

Market Signals
Indicator
BATRK
HAE
Relative Strength Index (RSI) 54.79 78.65
Support Level $48.51 $79.52
Resistance Level $54.46 N/A
Average True Range (ATR) 1.37 3.12
MACD 0.09 1.61
Stochastic Oscillator 69.13 90.50

Price Performance

Historical Comparison
BATRK
HAE

About BATRK Atlanta Braves Holdings Inc. Series C

Atlanta Braves Holdings Inc is a holding company. It operates through its wholly-owned subsidiary, which is the owner and operator of the Atlanta Braves Major League Baseball Club and the mixed-use real estate development, The Battery Atlanta, and is the operator of the Atlanta Braves Major League Baseball Club's stadium, Truist Park. The company predominantly derives revenue related to the Braves baseball franchise and Truist Park from ticket sales, concessions, local broadcasting rights, advertising sponsorships, suites and premium seat fees, retail and licensing revenue, shared MLB revenue streams, including national broadcasting rights and licensing, and other sources. The company's reportable segments include: Baseball which generates key revenue, and Mixed-Use Development.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: